NCT04911361View on ClinicalTrials.gov

The DEPOT Study (Dry Eye Prescription Options for Therapy)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 10, 2021

Primary Completion Date

December 28, 2021

Study Completion Date

December 28, 2021

Conditions

Dry Eye

Interventions

DRUG

Dexamethasone

Patients will be randomized for either topical loteprednol suspension in both eyes (control group) or lower eyelid canaliculi DEXTENZA insertion (study group)

Trial Locations (3)

63131

Ophthalmology Associates, St Louis

92545

Inland Eye Specialists, Hemet

92653

Harvard Eye Associates, Laguna Hills

All Listed Sponsors

lead

Research Insight LLC

INDUSTRY

NCT04911361 - The DEPOT Study (Dry Eye Prescription Options for Therapy) | Biotech Hunter | Biotech Hunter